AnaChart vs MarketBeat: Which Analyst Tool Is Better? (2026)

Last updated: July 3, 2026

The short answer: Use MarketBeat if you want a free, broad ratings tracker — analyst consensus, a live feed of every upgrade and downgrade, insider trades, dividends, and screeners across US, UK, and Canadian stocks. Use AnaChart if you want to know whether the individual analyst behind a rating has actually met their targets on the stock in front of you — a free, per-stock price-target accuracy record going back to 2004. MarketBeat aggregates the ratings; AnaChart scores the analysts.

Take NVIDIA (NVDA). MarketBeat shows the consensus cleanly — 54 analysts, a Buy rating, an average target of $305.67 — and a live feed of recent calls, including Tigress’s Ivan Feinseth raising his target to $425 and D.A. Davidson’s Gil Luria reiterating Buy at $300. But next to each analyst the line reads “Subscribe to MarketBeat All Access for the analyst’s recommendation accuracy rating” — and even then, that rating is a single global score. AnaChart shows the per-stock truth for free: on NVIDIA specifically, Feinseth has hit 8 of his 9 price targets (88.9%), while Luria — equally bullish in the same feed — has hit just 11 of 19 (57.9%). Same raised targets, very different reliability on this stock, and no paywall to see it.

What MarketBeat Does Well

MarketBeat is a genuinely strong, mostly-free research hub. Its analyst-ratings tracker is more generous than many paid competitors: a real-time feed of every upgrade, downgrade, initiation, and price-target change, consensus ratings and targets that update over time, plus insider trades, dividends, earnings, news, and screeners across US, UK, and Canadian markets. It has tracked more than 750,000 analyst recommendations over the past decade, and All Access is inexpensive at $399 a year. For breadth and a fast read on where the Street stands, it is hard to beat for the price.

What AnaChart Measures Differently

AnaChart is narrower and deeper. Instead of aggregating ratings, it scores the analysts: every sell-side price target since 2004 is checked against what the stock actually did, producing a per-analyst, per-stock accuracy record — met ratio, performance score, time to target, and how long a rating has been held. Where MarketBeat tells you what the Street is saying and gates each analyst’s accuracy behind All Access as a single global score, AnaChart shows for free whether the specific analyst on the specific stock has actually met their targets.

AnaChart vs MarketBeat: Feature Comparison

Feature	AnaChart	MarketBeat
Primary focus	Per-stock analyst price-target accuracy	Broad ratings aggregation, news & research tools
Per-analyst accuracy on a stock	✓Free met ratio & score for every analyst, per stock	✗Gated behind All Access — and only a single global score
Accuracy method	Price-target fulfillment + conviction/speed score	Global ranking by returns of Buy recommendations
Data source	Computed in-house from its own 2004–2026 archive	Aggregated from third-party data providers
History depth	✓Every target & revision since 2004 (20+ years)	~the last decade of recommendations
Per-analyst price-target timeline vs events	✓Each analyst’s targets over time on one chart	✗Consensus-over-time + a ratings feed, not per-analyst
Multi-analyst chart overlay	✓Overlay 2+ analysts	✗No
Rating held since (per analyst)	✓Start date of each analyst’s current rating	✗Shows latest action dates only
Breadth (news, dividends, insiders, screeners, intl)	Focused on analyst accuracy	✓Extensive — incl. US/UK/Canada coverage
Free access & pricing	Free Basic tier; Advanced $45/month	Generous free ratings; All Access $399/yr (~$33/mo)

MarketBeat details verified against marketbeat.com as of June 2026.

NVIDIA: What the Ratings Feed Hides

MarketBeat’s NVDA feed lists every firm’s latest target. AnaChart adds the column that matters — how often each of those analysts has actually met their targets on NVIDIA:

Analyst (firm)	Recent NVDA call	NVDA targets met (AnaChart)
Ivan Feinseth (Tigress)	Strong-Buy, raised to $425	8/9 (88.9%)
Quinn Bolton (Needham)	Buy, $270	23/29 (79.3%)
Ross Seymore (Deutsche Bank)	Hold, $255	26/36 (72.2%)
Gil Luria (D.A. Davidson)	Buy, $300	11/19 (57.9%)

NVDA accuracy from AnaChart’s NVIDIA page; recent calls from MarketBeat, June 2026. On MarketBeat these analysts’ accuracy ratings require an All Access subscription; on AnaChart the per-stock met ratio is free.

How Each Treats Analyst Accuracy

MarketBeat ranks analysts globally, by the returns generated by their Buy recommendations over roughly the past decade, and its underlying ratings come from third-party data providers. It is a useful aggregate signal, but it is a single firm- or analyst-level score that does not tell you how an analyst has done on the specific stock you are researching — and that score sits behind the All Access paywall.

AnaChart computes accuracy itself, per stock, from its own archive. Each price target is checked against what the stock actually did: the met ratio counts how many of an analyst’s targets the stock reached, and the performance score weights the size and speed of correct calls while counting misses as zero. Because it is calculated per analyst, per stock, an analyst who looks strong in a global ranking can rank near the bottom on the one name you care about — and you can see it without paying.

Rating Tenure: How Long Has the Call Stood?

AnaChart shows the date each analyst’s current rating began — Deutsche Bank’s Ross Seymore, for example, has held his Hold on NVIDIA since 2014. A rating held through years of volatility signals conviction; one changed last week is a fresh, untested view. MarketBeat’s feed shows the date of the latest action, which tells you when something last moved, not how long the prevailing view has actually held.

Pricing and Access

MarketBeat: a generous free tier covers the ratings feed, consensus targets, insider trades, and news; All Access is $399/year (about $33/month) with a 30-day free trial and adds the per-analyst accuracy ratings, screeners, and portfolio tools. AnaChart: a free Basic tier (sample stocks without registration, the Nasdaq 100 with a free account); Advanced is $45/month with a 7-day free trial, unlocking all 5,617 US-listed stocks, per-stock performance scores, multi-analyst comparison, and alerts. Institutions can license the full dataset warehouse-native through Corporate Access on Snowflake or Google BigQuery.

Which Tool to Use — and When

Choose MarketBeat for breadth and a fast, mostly-free read on the Street: a live ratings feed, consensus targets, insider and dividend data, screeners, and coverage that spans US, UK, and Canadian stocks.

Choose AnaChart when the decision turns on a specific analyst on a specific stock — when you need to know, without a paywall, whether the person behind a Buy or a $425 target has actually been accurate on that name.

Use both. MarketBeat surfaces what the Street is saying across thousands of stocks; AnaChart tells you which of those analysts has earned the benefit of the doubt. (See also AnaChart vs TipRanks, vs StockAnalysis.com, and vs WallStreetZen.)

Start where the example did: pick a stock you own and check who has actually met their targets on it — NVIDIA’s analyst track records are open right now, no sign-up required, or browse the top performing analysts by sector.

Frequently Asked Questions

Is AnaChart or MarketBeat better for analyst ratings?

It depends on the question. MarketBeat is better for breadth and a free, real-time feed of analyst ratings, upgrades, and consensus targets across thousands of stocks. AnaChart is better for judging a specific analyst on a specific stock — a free, per-stock price-target accuracy record going back to 2004. Many investors use MarketBeat to track the ratings and AnaChart to vet the analysts behind them.

Does MarketBeat show analyst accuracy?

Yes, but with two limits. MarketBeat ranks analysts by the returns of their Buy recommendations over roughly the past decade, and that per-analyst accuracy rating sits behind its All Access subscription. It is also a single global score, not a per-stock record. AnaChart shows each analyst’s met ratio on every stock they cover, for free.

Where does MarketBeat get its analyst data?

MarketBeat’s ratings and price targets are aggregated from third-party data providers. AnaChart computes its accuracy metrics in-house from its own price-target database dating to 2004.

How much does MarketBeat cost?

MarketBeat has a generous free tier; its All Access plan is $399 per year (about $33 a month) with a 30-day free trial. AnaChart’s Advanced plan is $45 a month and is focused specifically on per-stock analyst accuracy.

Should I use AnaChart and MarketBeat together?

Yes — they complement each other. MarketBeat is the stronger tool for a broad, free read on ratings, news, dividends, and insider activity; AnaChart is the stronger tool for verifying whether the individual analysts behind those ratings have actually been accurate on the stocks you trade.

For institutional teams: AnaChart’s full analyst price-target and accuracy dataset — every analyst, every target and revision since 2004 — is available warehouse-native through AnaChart Corporate Access, delivered straight into Snowflake or Google BigQuery with no ETL.